Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene‐engineered advanced cell therapy products for treatment of haematological disorders

Metadata

Item Type:	Article
Authors/Creators:	Ghorashian, S. https://orcid.org/0000-0002-1555-2946 Sanderson, R. https://orcid.org/0000-0003-4915-2833 Lee, J. Black, A. O'Reilly, M.A. https://orcid.org/0000-0002-2702-397X Marks, D.I. Snowden, J. https://orcid.org/0000-0001-6819-3476 Richardson, D. Olavarria, E.
Copyright, Publisher and Additional Information:	© 2025 The Author(s). British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords:	CAR T cell therapy; cell therapy; gene therapy
Dates:	Accepted: 29 October 2025 Published (online): 25 November 2025 Published: 25 November 2025
Institution:	The University of Sheffield
Academic Units:	The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Date Deposited:	01 Dec 2025 09:55
Last Modified:	01 Dec 2025 09:55
Status:	Published online
Publisher:	Wiley
Refereed:	Yes
Identification Number:	10.1111/bjh.70247
Related URLs:	PubMed URL
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:234982

CORE (COnnecting REpositories)